Secarna Appoints Konstantin Petropoulos as CEO
Germany’s Secarna Pharmaceuticals has appointed Konstantin Petropoulos as CEO. He is stepping up from his previous role as the company’s chief business officer (CBO) and succeeds Alexander Gebauer, who is stepping down with immediate effect to focus his efforts on another company, Galimedix Therapeutics, that he has co-founded and is leading.
Gebauer will support Petropoulos in his new role to ensure a smooth transition.
Petropoulos joined Secarna in June 2023 as CBO. Most recently, he was CEO of AMW and, prior to that, held senior management positions at several biotech and pharma companies, including Leukocare, Bayer and MorphoSys. In his previous roles he has been responsible for major business development deals, including licensing/co-development agreements and strategic alliances, and brings extensive knowledge of portfolio strategy development, marketing and sales.
Petropoulos has a PhD in oncology from the Ludwig-Maximilians-University, Munich, Germany and an MBA from the University of Applied Sciences for Economics and Management in Essen, Germany.
© Secarna Pharmaceuticals
